États-Unis · Presse financière · Investor's Business Daily

The Big Caveat Behind Bristol Myers' Sales Guidance Boost

Publié par Investor's Business Daily · États-Unis il y a 2 h

Bristol Myers Squibb stock rose Thursday despite a "mixed bag" performance that included a miss from its biggest cancer drug. The post The Big Caveat Behind Bristol Myers' Sales…

Lire l'article complet sur Investor's Business Daily Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.investors.com)

The Big Caveat Behind Bristol Myers' Sales Guidance Boost

À lire aussi

ING Launches Buyback But Flags Job Cuts and Unit Restructuring

Fortinet Stock Sinks. Analysts Say a Key Revenue Driver May Have Peaked.

The Big Caveat Behind Bristol Myers' Sales Guidance Boost

Partager

À lire aussi

ING Launches Buyback But Flags Job Cuts and Unit Restructuring

Fortinet Stock Sinks. Analysts Say a Key Revenue Driver May Have Peaked.